tiprankstipranks
Health and Happiness (H&H) International Holdings Limited (HK:1112)
:1112
Want to see HK:1112 full AI Analyst Report?

Health and Happiness (H&H) International Holdings (1112) AI Stock Analysis

2 Followers

Top Page

HK:1112

Health and Happiness (H&H) International Holdings

(1112)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - Gpt-5.6Sol)
Rating:60Neutral
Price Target:
HK$18.50
â–²(0.33% Upside)
Action:Reiterated
Date:08/27/26
The score is mainly held back by volatile bottom-line performance and elevated leverage despite strong gross margins and positive free cash flow. Technicals are supportive with the stock above major moving averages, but the elevated RSI indicates it may be near overbought. Valuation is reasonable (P/E ~13.4, ~2% yield) but does not fully offset the earnings and balance-sheet risk.
Positive Factors
Strong Gross Margins
Sustained gross margins of roughly 60–64% indicate attractive unit economics in the branded nutrition portfolio. This provides room to absorb channel, marketing, and input-cost pressure while supporting ongoing product investment.
Negative Factors
Volatile Profitability
A loss followed by only a thin net-margin recovery shows that strong gross economics have not consistently translated into bottom-line earnings. Persistent cost, pricing, or product-mix pressure could limit reinvestment and shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Gross Margins
Sustained gross margins of roughly 60–64% indicate attractive unit economics in the branded nutrition portfolio. This provides room to absorb channel, marketing, and input-cost pressure while supporting ongoing product investment.
Read all positive factors

Health and Happiness (H&H) International Holdings (1112) vs. iShares MSCI Hong Kong ETF (EWH)

Health and Happiness (H&H) International Holdings Business Overview & Revenue Model

Company Description
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into...
How the Company Makes Money
H&H International Holdings makes money primarily by selling branded nutrition and wellness products to consumers through a mix of online and offline distribution channels. Its core revenue model is product sales (recognized when goods are delivere...

Health and Happiness (H&H) International Holdings Financial Statement Overview

Summary
Strong gross margins (~60–64%) and consistently positive free cash flow support the business, but profitability has been volatile (loss in 2024 and only a thin net margin recovery in 2025 ~1.4%). Elevated leverage (debt-to-equity ~1.5) and materially lower ROE (~3% in 2025) increase risk if earnings remain uneven.
Income Statement
58
Neutral
Balance Sheet
46
Neutral
Cash Flow
62
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.03B14.35B13.05B13.93B12.78B11.55B
Gross Profit10.26B8.96B7.92B8.47B7.70B7.25B
EBITDA2.62B1.78B1.37B2.04B1.87B1.42B
Net Income735.75M196.14M-53.72M581.85M611.78M508.48M
Balance Sheet
Total Assets19.48B19.41B18.84B20.04B20.96B20.28B
Cash, Cash Equivalents and Short-Term Investments1.99B1.73B1.60B1.45B2.30B2.40B
Total Debt7.72B9.06B9.36B9.22B9.67B9.48B
Total Liabilities12.97B13.42B13.03B13.75B14.82B14.40B
Stockholders Equity6.51B5.99B5.81B6.30B6.14B5.89B
Cash Flow
Free Cash Flow1.62B947.13M1.25B1.01B1.37B1.78B
Operating Cash Flow1.67B994.38M1.35B1.10B1.47B1.89B
Investing Cash Flow-214.86M-134.75M895.00K-52.07M-104.88M-4.01B
Financing Cash Flow-1.44B-794.56M-1.07B-1.99B-1.49B2.77B

Health and Happiness (H&H) International Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price18.44
Price Trends
50DMA
14.99
Positive
100DMA
13.36
Positive
200DMA
13.22
Positive
Market Momentum
MACD
0.88
Positive
RSI
59.40
Neutral
STOCH
-12.95
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1112, the sentiment is Positive. The current price of 18.44 is above the 20-day moving average (MA) of 16.41, above the 50-day MA of 14.99, and above the 200-day MA of 13.22, indicating a bullish trend. The MACD of 0.88 indicates Positive momentum. The RSI at 59.40 is Neutral, neither overbought nor oversold. The STOCH value of -12.95 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1112.

Health and Happiness (H&H) International Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
HK$6.43B24.629.30%2.73%-3.39%20.09%
63
Neutral
HK$22.87B11.267.29%8.21%-4.22%-30.99%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
HK$11.05B12.8311.77%5.67%24.27%―
60
Neutral
HK$33.44B5.8325.72%3.81%5.80%-9.69%
57
Neutral
HK$69.92B32.664.53%3.25%3.48%―
52
Neutral
HK$2.05B-2.87-11.03%4.35%-8.08%-376.61%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1112
Health and Happiness (H&H) International Holdings
17.28
3.51
25.50%
HK:0151
Want Want China Holdings
2.84
-2.78
-49.48%
HK:2319
China Mengniu Dairy Co
18.36
3.58
24.22%
HK:0345
Vitasoy International Holdings
6.40
-2.10
-24.70%
HK:1717
Ausnutria Dairy Corp. Ltd.
1.15
-1.36
-54.17%
HK:6186
China Feihe Limited
2.58
-1.34
-34.24%

Health and Happiness (H&H) International Holdings Corporate Events

H&H International Declares HKD 0.82 Interim Dividend for First Half 2026
Aug 25, 2026
Health and Happiness (HH) International Holdings has declared an interim ordinary cash dividend of HKD 0.82 per share for the six months ended 30 June 2026, payable in Hong Kong dollars. The ex-dividend date is set for 10 September 2026, with the ...
H&H International Profit Soars on Margin Expansion in First Half 2026
Aug 25, 2026
Health and Happiness (HH) International Holdings reported strong interim results for the six months ended 30 June 2026, with revenue rising 23.9% year-on-year to RMB8.70 billion and gross profit reaching RMB5.69 billion. The group’s EBITDA s...
H&H Secures US$330 Million Syndicated Refinancing Package
Aug 5, 2026
Health and Happiness (HH) International Holdings Limited has arranged new syndicated refinancing facilities totalling about US$330 million, comprising term loans of roughly US$320 million and a US$10 million revolving credit line. The package, led...
H&H Sets August Board Meeting to Review Interim Results and Dividend
Jul 20, 2026
Health and Happiness (HH) International Holdings Limited has scheduled a board meeting in Hong Kong on 25 August 2026 to review and approve the group’s interim results for the six months ended 30 June 2026. The board will also consider decla...
H&H’s Australian Subsidiary Appeals Adverse Tax Ruling
Jul 10, 2026
Health and Happiness (HH) International Holdings said its Australian subsidiary, Biostime Healthy Australia Pty Ltd, has filed a Notice of Appeal in the Federal Court of Australia challenging an adverse tax objection decision by the Australian Tax...
H&H lifts profit outlook on double-digit growth in nutrition segments
Jul 5, 2026
Health and Happiness (HH) International Holdings reported double-digit like-for-like revenue growth for the first half of 2026, driven by all three core divisions: Adult Nutrition and Care, Baby Nutrition and Care and Pet Nutrition and Care. The g...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 27, 2026